Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxinning tablets for carotid atherosclerotic plaque
ChiCTR2100054694Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 4 trial of Guanxinning in carotid atheroma (CAS) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Carotid artery intima-media thickness. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
Guanxinning
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR2100054694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054694.